The Role of the Reactive Oxygen Species Scavenger Agent, Astaxanthin, in the Protection of Cisplatin-Treated Patients Against Hearing Loss

References

• Knight KRG, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23(34):8588–8596. doi:10.1200/Jco.2004.00.535516314621
   PubMed Web of Science ®Google Scholar
• Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and otoprotection. Front Cell Neurosci. 2017;11:338. doi:10.3389/fncel.2017.0033829163050
   PubMed Web of Science ®Google Scholar
• Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications–a review. Mar Drugs. 2014;12(1):128–152. doi:10.3390/md1201012824402174
   PubMed Web of Science ®Google Scholar
• Kuroki T, Ikeda S, Okada T, et al. Astaxanthin ameliorates heat stress-induced impairment of blastocyst development in vitro:–astaxanthin colocalization with and action on mitochondria. J Assist Reprod Genet. 2013;30(5):623–631. doi:10.1007/s10815-013-9987-z23536152
   PubMed Web of Science ®Google Scholar
• Breglio AM, Rusheen AE, Shide ED, et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun. 2017;8(1):1654. doi:10.1038/s41467-017-01837-129162831
   PubMed Web of Science ®Google Scholar
• Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–378. doi:10.1016/j.ejphar.2014.07.02525058905
   PubMed Web of Science ®Google Scholar
• Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4(4):307–320. doi:10.1038/nrd169115789122
   PubMed Web of Science ®Google Scholar
• More SS, Akil O, Ianculescu AG, Geier EG, Lustig LR, Giacomini KM. Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci. 2010;30(28):9500–9509. doi:10.1523/JNEUROSCI.1544-10.201020631178
   PubMed Web of Science ®Google Scholar
• Shen DW, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64(3):706–721. doi:10.1124/pr.111.00563722659329
   PubMed Web of Science ®Google Scholar
• Ciarimboli G, Deuster D, Knief A, et al. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol. 2010;176(3):1169–1180. doi:10.2353/ajpath.2010.09061020110413
   PubMed Web of Science ®Google Scholar
• Thomas AJ, Hailey DW, Stawicki TM, et al. Functional Mechanotransduction Is Required for Cisplatin-Induced Hair Cell Death in the Zebrafish Lateral Line. J Neurosci. 2013;33(10):4405–4414. doi:10.1523/Jneurosci.3940-12.201323467357
   PubMed Web of Science ®Google Scholar
• La Fontaine S, Mercer JF. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys. 2007;463(2):149–167. doi:10.1016/j.abb.2007.04.02117531189
   PubMed Web of Science ®Google Scholar
• Mukherjea D, Jajoo S, Whitworth C, et al. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. J Neurosci. 2008;28(49):13056–13065. doi:10.1523/JNEUROSCI.1307-08.200819052196
   PubMed Web of Science ®Google Scholar
• Takumida M, Ishibashi T, Hamamoto T, Hirakawa K, Anniko M. Age-dependent changes in the expression of klotho protein, TRPV5 and TRPV6 in mouse inner ear. Acta Oto-Laryngol. 2009;129(12):1340–1350. doi:10.3109/00016480902725254
   PubMed Web of Science ®Google Scholar
• Takumida M, Anniko M. Expression of canonical transient receptor potential channel (TRPC) 1-7 in the mouse inner ear. Acta Oto-Laryngol. 2009;129(12):1351–1358. doi:10.3109/00016480902798350
   PubMed Web of Science ®Google Scholar
• Takumida M, Anniko M. Expression of transient receptor potential channel mucolipin (TRPML) and polycystine (TRPP) in the mouse inner ear. Acta Oto-Laryngol. 2010;130(2):196–203. doi:10.3109/00016480903013593
   PubMed Web of Science ®Google Scholar
• Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. P Natl Acad Sci USA. 2002;99(22):14298–14302. doi:10.1073/pnas.162491399
   PubMed Web of Science ®Google Scholar
• Waissbluth S, Daniel SJ. Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity. Hear Res. 2013;299:37–45. doi:10.1016/j.heares.2013.02.00223467171
   PubMed Web of Science ®Google Scholar
• Holzer AK, Samimi G, Katano K, et al. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Mol Pharmacol. 2004;66(4):817–823. doi:10.1124/mol.104.00119815229296
   PubMed Web of Science ®Google Scholar
• Budiman T, Bamberg E, Koepsell H, Nagel G. Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat. J Biol Chem. 2000;275(38):29413–29420. doi:10.1074/jbc.M00464520010889205
   PubMed Web of Science ®Google Scholar
• Pelis RM, Wright SH. SLC22, SLC44, and SLC47 transporters-organic anion and cation transporters: molecular and cellular properties. Curr Top Membr. 2014;73:233–261. doi:10.1016/B978-0-12-800223-0.00006-224745985
   PubMed Web of Science ®Google Scholar
• Schaeffeler E, Hellerbrand C, Nies AT, et al. DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma. Genome Med. 2011;3:82. doi:10.1186/gm29822196450
   PubMed Web of Science ®Google Scholar
• Bleasby K, Castle JC, Roberts CJ, et al. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica. 2006;36(10–11):963–988. doi:10.1080/0049825060086175117118916
   PubMed Web of Science ®Google Scholar
• Hellberg V, Gahm C, Liu W, Ehrsson H, Rask-Andersen H, Laurell G. Immunohistochemical localization of OCT2 in the cochlea of various species. Laryngoscope. 2015;125(9):E320–E325. doi:10.1002/lary.2530425892279
   PubMed Web of Science ®Google Scholar
• Lanvers-Kaminsky C, Sprowl JA, Malath I, et al. Human OCT2 variant c.808G > T confers protection effect against cisplatin-induced ototoxicity. Pharmacogenomics. 2015;16(4):323–332. doi:10.2217/Pgs.14.18225823781
   PubMed Web of Science ®Google Scholar
• Samimi G, Safaei R, Katano K, et al. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res. 2004;10(14):4661–4669. doi:10.1158/1078-0432.CCR-04-013715269138
   PubMed Web of Science ®Google Scholar
• Yoshizawa K, Nozaki S, Kitahara H, Ohara T et al. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Oncol Rep. 2007;18(4):987–991. PMID:1778636417786364
   PubMed Web of Science ®Google Scholar
• Ding D, He J, Allman BL, et al. Cisplatin ototoxicity in rat cochlear organotypic cultures. Hear Res. 2011;282(1–2):196–203. doi:10.1016/j.heares.2011.08.00221854840
   PubMed Web of Science ®Google Scholar
• Tadini-Buoninsegni F, Sordi G, Smeazzetto S, Natile G, Arnesano F. Effect of cisplatin on the transport activity of P-II-type ATPases. Metallomics. 2017;9(7):960–968. doi:10.1039/c7mt00100b28636017
   PubMed Web of Science ®Google Scholar
• Min XJ, Li H, Hou SC, et al. Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells. Exp Biol Med (Maywood). 2011;236(4):483–491. doi:10.1258/ebm.2011.01029721454376
   PubMed Web of Science ®Google Scholar
• Lee EL, Shimizu T, Ise T, Numata T, Kohno K, Okada Y. Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells. J Cell Physiol. 2007;211(2):513–521. doi:10.1002/jcp.2096117186499
   PubMed Web of Science ®Google Scholar
• Planells‐Cases R, Lutter D, Guyader C, et al. Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs. EMBO J. 2015;34(24):2993–3008. doi:10.15252/embj.20159240926530471
   PubMed Web of Science ®Google Scholar
• Yamasaki M, Makino T, Masuzawa T, et al. Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma. Br J Cancer. 2011;104(4):707–713. doi:10.1038/sj.bjc.660607121206495
   PubMed Web of Science ®Google Scholar
• Korita PV, Wakai T, Shirai Y, et al. Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma. Oncol Rep. 2010;23(4):965–972. doi:10.3892/or_0000072120204280
   PubMed Web of Science ®Google Scholar
• Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta. 2009;1787(5):414–420. doi:10.1016/j.bbabio.2008.10.00519007744
   PubMed Web of Science ®Google Scholar
• Rybak LP, Ramkumar V. Ototoxicity. Kidney Int. 2007;72(8):931–935. doi:10.1038/sj.ki.500243417653135
   PubMed Web of Science ®Google Scholar
• Seidman MD, Quirk WS, Nuttall AL, Schweitzer VG. The protective effects of allopurinol and superoxide dismutase-polyethylene glycol on ischemic and reperfusion-induced cochlear damage. Otolaryngol Head Neck Surg. 1991;105(3):457–463. doi:10.1177/0194599891105003181945435
   PubMed Web of Science ®Google Scholar
• Kopke RD, Liu W, Gabaizadeh R, et al. Use of organotypic cultures of Corti’s organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol. 1997;18(5):559–571. PMID:9303151 9303151
   PubMedGoogle Scholar
• Clerici WJ, Yang LH. Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hearing Res. 1996;101(1–2):14–22. doi:10.1016/S0378-5955(96)00126-8
   PubMed Web of Science ®Google Scholar
• Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol. 2000;21(4):513–520. PMID:1091269710912697
   PubMedGoogle Scholar
• DeWoskin R, Riviere J. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna. Toxicol Appl Pharmacol. 1992;112(2):182–189. doi:10.1016/0041-008x(92)90186-v1311464
   PubMed Web of Science ®Google Scholar
• Gao HM, Zhou H, Hong JS. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol Sci. 2012;33(6):295–303. doi:10.1016/j.tips.2012.03.00822503440
   PubMed Web of Science ®Google Scholar
• Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J. 1980;191(2):421–427. doi:10.1042/bj19104216263247
   PubMed Web of Science ®Google Scholar
• Mukherjea D, Jajoo S, Kaur T, Sheehan KE, Ramkumar V, Rybak LP. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxid Redox Signal. 2010;13(5):589–598. doi:10.1089/ars.2010.311020214492
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee JH, Kim SJ, et al. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J Neurosci. 2010;30(11):3933–3946. doi:10.1523/JNEUROSCI.6054-09.201020237264
   PubMed Web of Science ®Google Scholar
• Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, Krause KH. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem. 2004;279(44):46065–46072. doi:10.1074/jbc.M40304620015326186
   PubMed Web of Science ®Google Scholar
• Kim HJ, Oh GS, Lee JH, et al. Cisplatin ototoxicity involves cytokines and STAT6 signaling network. Cell Res. 2011;21(6):944–956. doi:10.1038/cr.2011.2721321603
   PubMed Web of Science ®Google Scholar
• Kaur T, Mukherjea D, Sheehan K, Jajoo S, Rybak LP, Ramkumar V. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death Dis. 2011;2:e180. doi:10.1038/cddis.2011.6321776018
   PubMed Web of Science ®Google Scholar
• Schmitt NC, Rubel EW, Nathanson NM. Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate. J Neurosci. 2009;29(12):3843–3851. doi:10.1523/Jneurosci.5842-08.200919321781
   PubMed Web of Science ®Google Scholar
• Qi MH, Qiu Y, Zhou XY, et al. Regional up-regulation of NOX2 contributes to the differential vulnerability of outer hair cells to neomycin. Biochem Bioph Res Co. 2018;500(2):110–116. doi:10.1016/j.bbrc.2018.03.141
   PubMed Web of Science ®Google Scholar
• McNally JS, Saxena A, Cai H, Dikalov S, Harrison DG. Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscl Throm Vas. 2005;25(8):1623–1628. doi:10.1161/01.ATV.0000170827.16296.6e
   Web of Science ®Google Scholar
• Lynch ED, Gu R, Pierce C, Kil J. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res. 2005;201(1–2):81–89. doi:10.1016/j.heares.2004.08.00215721563
   PubMed Web of Science ®Google Scholar
• Kinugasa Y, Ogino K, Furuse Y, et al. Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ J. 2003;67(9):781–787. doi:10.1253/circj.67.78112939555
   PubMed Web of Science ®Google Scholar
• Jones QR, Warford J, Rupasinghe HP, Robertson GS. Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci. 2012;33(11):602–610. doi:10.1016/j.tips.2012.08.00222980637
   PubMed Web of Science ®Google Scholar
• Lee JS, Kang SU, Hwang HS, Pyun JH, Choung YH, Kim CH. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. Toxicol Lett. 2010;199(3):308–316. doi:10.1016/j.toxlet.2010.09.01320883750
   PubMed Web of Science ®Google Scholar
• Tabuchi K, Nishimura B, Nakamagoe M, Hayashi K, Nakayama M, Hara A. Ototoxicity: mechanisms of cochlear impairment and its prevention. Curr Med Chem. 2011;18(31):4866–4871. doi:10.2174/09298671179753525421919841
   PubMed Web of Science ®Google Scholar
• Cai JY, Yang J, Jones DP. Mitochondrial control of apoptosis: the role of cytochrome c. Bba-Bioenergetics. 1998;1366(1–2):139–149. doi:10.1016/S0005-2728(98)00109-19714780
   PubMed Web of Science ®Google Scholar
• Lu YK, Cederbaum AI. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci. 2006;89(2):515–523. doi:10.1093/toxsci/kfj03116251482
   PubMed Web of Science ®Google Scholar
• Liu H, Baliga M, Baliga R. Effect of cytochrome p450 2E1 inhibitors on cisplatin-induced cytotoxicity to renal proximal tubular epithelial cells. Anticancer Res. 2002;22(2a):863–868. PMID:1201466312014663
   PubMed Web of Science ®Google Scholar
• Liu H, Baliga R. Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int. 2003;63(5):1687–1696. doi:10.1046/j.1523-1755.2003.00908.x12675844
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum A. The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin. Free Radical Bio Med. 2007;43(7):1061–1075. doi:10.1016/j.freeradbiomed.2007.06.02117761302
   PubMed Web of Science ®Google Scholar
• Watanabe K, Hess A, Bloch W, Michel O. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatin. Anti-Cancer Drug. 2000;11(1):29–32. doi:10.1097/00001813-200001000-00005
   PubMed Web of Science ®Google Scholar
• Watanabe K, Inai S, Jinnouchi K, et al. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice. Anticancer Res. 2002;22(6C):4081–4085. PMID:1255303612553036
   PubMed Web of Science ®Google Scholar
• Ruan RS. Possible roles of nitric oxide in the physiology and pathophysiology of the mammalian cochlea. Ann N Y Acad Sci. 2002;962:260–274. doi:10.1111/j.1749-6632.2002.tb04073.x12076980
   PubMed Web of Science ®Google Scholar
• Rybak LP. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg. 2007;15(5):364–369. doi:10.1097/MOO.0b013e3282eee45217823555
   PubMedGoogle Scholar
• Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res. 2007;226(1–2):157–167. doi:10.1016/j.heares.2006.09.01517113254
   PubMed Web of Science ®Google Scholar
• Bauer NC, Corbett AH, Doetsch PW. The current state of eukaryotic DNA base damage and repair. Nucleic Acids Res. 2015;43(21):10083–10101. doi:10.1093/nar/gkv113626519467
   PubMed Web of Science ®Google Scholar
• Friedberg EC. A history of the DNA repair and mutagenesis field The discovery of base excision repair. DNA Repair (Amst). 2016;37:A35–A39. doi:10.1016/j.dnarep.2015.12.00326861186
   PubMed Web of Science ®Google Scholar
• Miller JH, Goodman MF. Tomas Lindahl: 2015 Nobel Laureate. DNA Repair (Amst). 2016;37:A29–A34. doi:10.1016/j.dnarep.2015.12.00626861184
   PubMed Web of Science ®Google Scholar
• Radman M. Mismatch repair earns Nobel Prize in Chemistry 2015 to Paul Modrich for a biochemical tour de force. DNA Repair (Amst). 2016;37:A22–A28. doi:10.1016/j.dnarep.2015.12.00426861183
   PubMed Web of Science ®Google Scholar
• Van Houten B. A tale of two cities: a tribute to Aziz Sancar’s Nobel Prize in Chemistry for his molecular characterization of NER. DNA Repair (Amst). 2016;37:A3–A13. doi:10.1016/j.dnarep.2015.12.00226861185
   PubMed Web of Science ®Google Scholar
• Cadet J, Davies KJA. Oxidative DNA damage & repair: an introduction. Free Radic Biol Med. 2017;107:2–12. doi:10.1016/j.freeradbiomed.2017.03.03028363603
   PubMed Web of Science ®Google Scholar
• Santa-Gonzalez GA, Gomez-Molina A, Arcos-Burgos M, Meyer JN, Camargo M. Distinctive adaptive response to repeated exposure to hydrogen peroxide associated with upregulation of DNA repair genes and cell cycle arrest. Redox Biol. 2016;9:124–133. doi:10.1016/j.redox.2016.07.00427479053
   PubMed Web of Science ®Google Scholar
• Van Houten B, Santa-Gonzalez GA, Camargo M. DNA repair after oxidative stress: current challenges. Curr Opin Toxicol. 2018;7:9–16. doi:10.1016/j.cotox.2017.10.00929159324
   PubMedGoogle Scholar
• Kim HJ, Oh GS, Shen A, et al. Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment. Cell Death Dis. 2014;5:e1292.24922076
   PubMed Web of Science ®Google Scholar
• Gentilin E, Simoni E, Candito M, Cazzador D, Astolfi L. Cisplatin-induced ototoxicity: updates on molecular targets. Trends Mol Med. 2019;S1471-4914(19):30210–33012. doi:10.1016/j.molmed.2019.08.002
   Web of Science ®Google Scholar
• Lorenz RT, Cysewski GR. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol. 2000;18(4):160–167. doi:10.1016/S0167-7799(00)01433-510740262
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Dawson VL, Dawson TM. Free radicals as mediators of neuronal injury. Cell Mol Neurobiol. 1998;18(6):667–682. doi:10.1023/A:10202219191549876873
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim H. Inhibitory effect of astaxanthin on oxidative stress-induced mitochondrial dysfunction-a mini-review. Nutrients. 2018;10(9). doi:10.3390/nu10091137
   Web of Science ®Google Scholar
• Bae JW, Kim MJ, Jang CG, Lee SY. Protective effects of heme oxygenase-1 against MPP+-induced cytotoxicity in PC-12 cells. Neurol Sci. 2010;31(3):307–313. doi:10.1007/s10072-010-0216-620127499
   PubMed Web of Science ®Google Scholar
• Borlongan CV, Kanning K, Poulos SG, Freeman TB, Cahill DW, Sanberg PR. Free radical damage and oxidative stress in Huntington’s disease. J Fla Med Assoc. 1996;83(5):335–341. PMID: 86669728666972
   PubMedGoogle Scholar
• Ferrante RJ, Browne SE, Shinobu LA, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem. 1997;69(5):2064–2074.9349552
   PubMed Web of Science ®Google Scholar
• Rebrin I, Zicker S, Wedekind KJ, Paetau-Robinson I, Packer L, Sohal RS. Effect of anti-oxidant-enriched diets on glutathione redox status in tissue homogenates and mitochondria of the senescence-accelerated mouse. Free Radical Bio Med. 2005;39(4):549–557. doi:10.1016/j.freeradbiomed.2005.04.00816043026
   PubMed Web of Science ®Google Scholar
• Chang CH, Chen CY, Chiou JY, Peng RY, Peng CH. Astaxanthine secured apoptotic death of PC12 cells induced by beta-amyloid peptide 25-35: its molecular action targets. J Med Food. 2010;13(3):548–556. doi:10.1089/jmf.2009.129120521980
   PubMed Web of Science ®Google Scholar
• Che HX, Li Q, Zhang TT, et al. Effects of astaxanthin and docosahexaenoic-acid-acylated astaxanthin on Alzheimer’s disease in APP/PS1 double-transgenic mice. J Agr Food Chem. 2018;66(19):4948–4957. doi:10.1021/acs.jafc.8b0098829695154
   PubMed Web of Science ®Google Scholar
• Lee DH, Kim CS, Lee YJ. Astaxanthin protects against MPTP/MPP plus -induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem Toxicol. 2011;49(1):271–280. doi:10.1016/j.fct.2010.10.02921056612
   PubMed Web of Science ®Google Scholar
• Kim JH, Choi W, Lee JH, et al. Astaxanthin inhibits H2O2-mediated apoptotic cell death in mouse neural progenitor cells via modulation of P38 and MEK signaling pathways. J Microbiol Biotechn. 2009;19(11):1355–1363. doi:10.4014/jmb.0906.06003
   PubMed Web of Science ®Google Scholar
• Al-Amin MM, Reza HM, Saadi HM, et al. Astaxanthin ameliorates aluminum chloride-induced spatial memory impairment and neuronal oxidative stress in mice. Eur J Pharmacol. 2016;777:60–69. doi:10.1016/j.ejphar.2016.02.06226927754
   PubMed Web of Science ®Google Scholar
• Tso Mark OM, Lam Tim-Tak. Method of retarding and ameliorating central nervous system and eye damage. Google Patents 1996;167.
   Google Scholar
• Shen H, Kuo CC, Chou J, et al. Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 2009;23(6):1958–1968. doi:10.1096/fj.08-12328119218497
   PubMed Web of Science ®Google Scholar
• Wu W, Wang X, Xiang Q, et al. Astaxanthin alleviates brain aging in rats by attenuating oxidative stress and increasing BDNF levels. Food Funct. 2014;5(1):158–166. doi:10.1039/c3fo60400d24326685
   PubMed Web of Science ®Google Scholar
• Gross GJ, Hazen SL, Lockwood SF. Seven day oral supplementation with Cardax (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats. Mol Cell Biochem. 2006;283(1–2):23–30. doi:10.1007/s11010-006-2217-616444582
   PubMed Web of Science ®Google Scholar
• Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101(10A):58D–68D. doi:10.1016/j.amjcard.2008.02.01018157966
   PubMed Web of Science ®Google Scholar
• Nakao R, Nelson OL, Park JS, Mathison BD, Thompson PA, Chew BP. Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice. Anticancer Res. 2010;30(7):2721–2725. PMID:2068300420683004
   PubMed Web of Science ®Google Scholar
• Abdelzaher LA, Imaizumi T, Suzuki T, Tomita K, Takashina M, Hattori Y. Astaxanthin alleviates oxidative stress insults-related derangements in human vascular endothelial cells exposed to glucose fluctuations. Life Sci. 2016;150:24–31. doi:10.1016/j.lfs.2016.02.08726924495
   PubMed Web of Science ®Google Scholar
• Alam MN, Hossain MM, Rahman MM, et al. Astaxanthin prevented oxidative stress in heart and kidneys of isoproterenol-administered aged rats. J Diet Suppl. 2018;15(1):42–54. doi:10.1080/19390211.2017.132107828489954
   PubMedGoogle Scholar
• Pongkan W, Takatori O, Ni YH, et al. beta-Cryptoxanthin exerts greater cardioprotective effects on cardiac ischemia-reperfusion injury than astaxanthin by attenuating mitochondrial dysfunction in mice. Mol Nutr Food Res. 2017;61(10). doi:10.1002/mnfr.201601077
   PubMed Web of Science ®Google Scholar
• Fan CD, Sun JY, Fu XT, et al. Astaxanthin attenuates homocysteine-induced cardiotoxicity in vitro and in vivo by inhibiting mitochondrial dysfunction and oxidative damage. Front Physiol. 2017;8. doi:10.3389/fphys.2017.01041
   Web of Science ®Google Scholar
• Gammone MA, Riccioni G, D’Orazio N. Carotenoids: potential allies of cardiovascular health? Food Nutr Res. 2015;59:26762. doi:10.3402/fnr.v59.2676225660385
   PubMed Web of Science ®Google Scholar
• Ni Y, Nagashimada M, Zhuge F, et al. Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: a comparison with vitamin E. Sci Rep. 2015;5:17192. doi:10.1038/srep1719226603489
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang S, Bi J, Gu J, Deng Y, Liu C. Astaxanthin pretreatment attenuates acetaminophen-induced liver injury in mice. Int Immunopharmacol. 2017;45:26–33. doi:10.1016/j.intimp.2017.01.02828152447
   PubMed Web of Science ®Google Scholar
• Takahashi K, Watanabe M, Takimoto T, Akiba Y. Uptake and distribution of astaxanthin in several tissues and plasma lipoproteins in male broiler chickens fed a yeast (Phaffia rhodozyma) with a high concentration of astaxanthin. Brit Poultry Sci. 2004;45(1):133–138. doi:10.1080/0007166041000166895015115211
   PubMed Web of Science ®Google Scholar
• Rao AR, Sindhuja HN, Dharmesh SM, Sankar KU, Sarada R, Ravishankar GA. Effective inhibition of skin cancer, tyrosinase, and antioxidative properties by astaxanthin and astaxanthin esters from the green alga haematococcus pluvialis. J Agr Food Chem. 2013;61(16):3842–3851. doi:10.1021/jf304609j23473626
   PubMed Web of Science ®Google Scholar
• Park JS, Chyun JH, Kim YK, Line LL, Chew BP. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab. 2010;7:18. doi:10.1186/1743-7075-7-18
   Google Scholar
• Tominaga K, Hongo N, Fujishita M, Takahashi Y, Adachi Y. Protective effects of astaxanthin on skin deterioration. J Clin Biochem Nutr. 2017;61(1):33–39. doi:10.3164/jcbn.17-3528751807
   PubMed Web of Science ®Google Scholar
• Yoon HS, Cho HH, Cho S, Lee SR, Shin MH, Chung JH. Supplementating with dietary astaxanthin combined with collagen hydrolysate improves facial elasticity and decreases matrix metalloproteinase-1 and −12 expression: a comparative study with placebo. J Med Food. 2014;17(7):810–816. doi:10.1089/jmf.2013.306024955642
   PubMed Web of Science ®Google Scholar
• Tominaga K, Hongo N, Karato M, Yamashita E. Cosmetic benefits of astaxanthin on humans subjects. Acta Biochim Pol. 2012;59(1):43–47. doi:10.18388/abp.2012_216822428137
   PubMed Web of Science ®Google Scholar
• Fang Q, Guo S, Zhou H, Han R, Wu P, Han C. Astaxanthin protects against early burn-wound progression in rats by attenuating oxidative stress-induced inflammation and mitochondria-related apoptosis. Sci Rep. 2017;7:41440. doi:10.1038/srep4144028128352
   PubMed Web of Science ®Google Scholar
• Meephansan J, Rungjang A, Yingmema W, Deenonpoe R, Ponnikorn S. Effect of astaxanthin on cutaneous wound healing. Clin Cosmet Investig Dermatol. 2017;10:259–265. doi:10.2147/CCID.S142795
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang H. Multiple mechanisms of anti-cancer effects exerted by astaxanthin. Mar Drugs. 2015;13(7):4310–4330. doi:10.3390/md1307431026184238
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85–95. doi:10.1038/nrc298121258394
   PubMed Web of Science ®Google Scholar
• Kavitha K, Kowshik J, Kishore TK, Baba AB, Nagini S. Astaxanthin inhibits NF-kappaB and Wnt/beta-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim Biophys Acta. 2013;1830(10):4433–4444. doi:10.1016/j.bbagen.2013.05.03223726989
   PubMed Web of Science ®Google Scholar
• Nagendraprabhu P, Sudhandiran G. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest New Drugs. 2011;29(2):207–224. doi:10.1007/s10637-009-9342-519876598
   PubMed Web of Science ®Google Scholar
• Song XD, Zhang JJ, Wang MR, Liu WB, Gu XB, Lv CJ. Astaxanthin induces mitochondria-mediated apoptosis in rat hepatocellular carcinoma CBRH-7919 cells. Biol Pharm Bull. 2011;34(6):839–844. doi:10.1248/bpb.34.83921628881
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao WE, Hu L, Zhao L, Huang J. Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARgamma) in K562 cancer cells. Arch Biochem Biophys. 2011;512(1):96–106. doi:10.1016/j.abb.2011.05.00421620794
   PubMed Web of Science ®Google Scholar
• Su XZ, Chen R, Wang CB, Ouyang XL, Jiang Y, Zhu MY. Astaxanthin combine with human serum albumin to abrogate cell proliferation, migration, and drug-resistant in human ovarian carcinoma SKOV3 cells. Anticancer Agents Med Chem. 2019;19(6):792–801. doi:10.2174/187152061966619022512300330799797
   PubMed Web of Science ®Google Scholar
• Goto S, Kogure K, Abe K, et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Bba-Biomembranes. 2001;1512(2):251–258. doi:10.1016/S0005-2736(01)00326-111406102
   PubMed Web of Science ®Google Scholar
• Santa-Maria AR, Walter FR, Valkai S, et al. Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models. Bba-Biomembranes. 2019;1861(9):1579–1591. doi:10.1016/j.bbamem.2019.07.00831301276
   PubMed Web of Science ®Google Scholar
• Matsushita Y, Suzuki R, Nara E, Yokoyama A, Miyashita K. Anti-oxidant activity of polar carotenoids including astaxanthin-β-glucoside from marine bacterium on PC liposomes. Fish Sci. 2000;66(5):980–985. doi:10.1046/j.1444-2906.2000.00155.x
   Web of Science ®Google Scholar
• Greene LS. Asthma and oxidant stress - nutritional, environmental, and genetic risk-factors. J Am Coll Nutr. 1995;14(4):317–324. doi:10.1080/07315724.1995.107185168568107
   PubMed Web of Science ®Google Scholar
• Dekkers JC, van Doornen LJP, Kemper HCG. The role of anti-oxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Med. 1996;21(3):213–238. doi:10.2165/00007256-199621030-000058776010
   PubMed Web of Science ®Google Scholar
• Bennedsen M, Wang X, Willen R, Wadstrom T, Andersen LP. Treatment of H-pylori infected mice with anti-oxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol Lett. 1999;70(3):185–189. doi:10.1016/S0165-2478(99)00145-510656672
   PubMed Web of Science ®Google Scholar
• Higuera-Ciapara I, Felix-Valenzuela L, Goycoolea FM. Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci. 2006;46(2):185–196. doi:10.1080/10408690590957188
   PubMed Web of Science ®Google Scholar
• Wolf AM, Asoh S, Hiranuma H, et al. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem. 2010;21(5):381–389. doi:10.1016/j.jnutbio.2009.01.01119423317
   PubMed Web of Science ®Google Scholar
• Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev. 2011;16(4):355–364.22214255
   PubMedGoogle Scholar
• Osterlie M, Bjerkeng B, Liaaen-Jensen S. Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J Nutr Biochem. 2000;11(10):482–490. doi:10.1016/S0955-2863(00)00104-2 PMID:2221425511120445
   PubMed Web of Science ®Google Scholar
• Yan TT, Zhao Y, Zhang X, Lin XT. Astaxanthin inhibits acetaldehyde-induced cytotoxicity in sh-sy5y cells by modulating Akt/CREB and p38MAPK/ERK signaling pathways. Mar Drugs. 2016;14(3):56. doi:10.3390/md14030056
   PubMed Web of Science ®Google Scholar
• Li JJ, Wang F, Xia YJ, et al. Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS/MAPK pathway in mice. Mar Drugs. 2015;13(6):3368–3387. doi:10.3390/md1306336826023842
   PubMed Web of Science ®Google Scholar
• Yang X, Guo AL, Pang YP, et al. Astaxanthin attenuates environmental tobacco smoke-induced cognitive deficits: a critical role of p38 MAPK. Mar Drugs. 2019;17(1):24. doi:10.3390/md17010024
   PubMed Web of Science ®Google Scholar
• Niu TT, Xuan RR, Jiang LG, et al. Astaxanthin induces the Nrf2/HO-1 anti-oxidant pathway in human umbilical vein endothelial cells by generating trace amounts of ROS. J Agr Food Chem. 2018;66(6):1551–1559. doi:10.1021/acs.jafc.7b0549329381356
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhang XS, Wang HD, et al. Astaxanthin activates nuclear factor erythroid-related factor 2 and the anti-oxidant responsive element (Nrf2-ARE) pathway in the brain after subarachnoid hemorrhage in rats and attenuates early brain injury. Mar Drugs. 2014;12(12):6125–6141. doi:10.3390/md1212612525528957
   PubMed Web of Science ®Google Scholar
• Wu ML, Ho YC, Yet SF. A central role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Sign. 2011;15(7):1835–1846. doi:10.1089/ars.2010.3726
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Talalay P. NAD(P)H:quinoneacceptor oxidoreductase 1 (NQO1), a multifunctional anti-oxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010;501(1):116–123. doi:10.1016/j.abb.2010.03.01920361926
   PubMed Web of Science ®Google Scholar
• Pan L, Zhou Y, Li XF, Wan QJ, Yu LH. Preventive treatment of astaxanthin provides neuroprotection through suppression of reactive oxygen species and activation of anti-oxidant defense pathway after stroke in rats. Brain Res Bull. 2017;130:211–220. doi:10.1016/j.brainresbull.2017.01.02428161193
   PubMed Web of Science ®Google Scholar
• Tripathi DN, Jena GB. Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. Mutat Res-Gen Tox En. 2010;696(1):69–80. doi:10.1016/j.mrgentox.2009.12.014
   PubMed Web of Science ®Google Scholar
• Nakanishi A, Wada Y, Kitagishi Y, Matsuda S. Link between PI3K/AKT/PTEN pathway and NOX protein in diseases. Aging Dis. 2014;5(3):203–211. doi:10.14336/Ad.2014.050020324900943
   PubMed Web of Science ®Google Scholar
• Wang CM, Cai XL, Wen QP. Astaxanthin reduces isoflurane-induced neuroapoptosis via the PI3K/Akt pathway. Mol Med Rep. 2016;13(5):4073–4078. doi:10.3892/mmr.2016.503527035665
   PubMed Web of Science ®Google Scholar
• Zuluaga M, Barzegari A, Letourneur D, Gueguen V, Pavon-Djavid G. Oxidative stress regulation on endothelial cells by hydrophilic astaxanthin complex: chemical, biological, and molecular anti-oxidant activity evaluation. Oxid Med Cell Longev. 2017;2017:1–15. doi:10.1155/2017/8073798
   Web of Science ®Google Scholar
• Li ZR, Dong X, Liu HL, et al. Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated Phase II enzymes through activation of PI3K/Akt. Mol Vis. 2013;19:1656–1666.23901249
   PubMed Web of Science ®Google Scholar
• Ye QY, Zhang XD, Huang BX, Zhu YG, Chen XC. Astaxanthin suppresses MPP+-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar Drugs. 2013;11(4):1019–1034. doi:10.3390/md1104101923538867
   PubMed Web of Science ®Google Scholar
• Takemoto Y, Hirose Y, Sugahara K, Hashimoto M, Hara H, Yamashita H. Protective effect of an astaxanthin nanoemulsion against neomycin-induced hair-cell damage in zebrafish. Auris Nasus Larynx. 2018;45(1):20–25. doi:10.1016/j.anl.2017.02.00128274503
   PubMed Web of Science ®Google Scholar